Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Dron

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
American Journal of Respiratory Cell and Molecular Biology|June 20, 2015
Deficiency Mutations of Alpha-1 Antitrypsin. Effects on Folding, Function, and PolymerizationImran Haq, James A Irving, Aarash D Saleh, et al.
BMJ Global Health|August 9, 2020
Prevalence and incidence of HIV among female sex workers and their clients: modelling the potential effects of intervention in RwandaSabin Nsanzimana, Edward J Mills, Ofir Harari, et al.
JAMA Network Open|July 27, 2019
Association of Early Interventions With Birth Outcomes and Child Linear Growth in Low-Income and Middle-Income Countries: Bayesian Network Meta-analyses of Randomized Clinical TrialsJay J H Park, Mei Lan Fang, Ofir Harari, et al.
United European Gastroenterology Journal|October 25, 2024
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION studyStefan Schreiber, Brian G Feagan, Edouard Louis, et al.
Clinical and Experimental Immunology|December 14, 2024
Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled studyJohn Whalen, Anita Chandra, Sven Kracker, et al.
Contemporary Clinical Trials|December 6, 2020
Reporting and design of randomized controlled trials for COVID-19: A systematic reviewAlison Dillman, Jay J H Park, Michael J Zoratti, et al.
The Lancet. Global Health|April 18, 2021
The role and challenges of cluster randomised trials for global healthLouis Dron, Monica Taljaard, Yin Bun Cheung, et al.
JAMA Network Open|July 12, 2022
Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional TrialsJay J H Park, Behnam Sharif, Ofir Harari, et al.
Clinical and Translational Science|July 19, 2023
Totality of evidence of the effectiveness of repurposed therapies for COVID-19: Can we use real-world studies alongside randomized controlled trials?Jaap Mandema, Hugh Montgomery, Louis Dron, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19Craig R Rayner, Louis Dron, Jay J H Park, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory Cell and Molecular Biology|June 20, 2015
Deficiency Mutations of Alpha-1 Antitrypsin. Effects on Folding, Function, and PolymerizationImran Haq, James A Irving, Aarash D Saleh, et al.
BMJ Global Health|August 9, 2020
Prevalence and incidence of HIV among female sex workers and their clients: modelling the potential effects of intervention in RwandaSabin Nsanzimana, Edward J Mills, Ofir Harari, et al.
JAMA Network Open|July 27, 2019
Association of Early Interventions With Birth Outcomes and Child Linear Growth in Low-Income and Middle-Income Countries: Bayesian Network Meta-analyses of Randomized Clinical TrialsJay J H Park, Mei Lan Fang, Ofir Harari, et al.
United European Gastroenterology Journal|October 25, 2024
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION studyStefan Schreiber, Brian G Feagan, Edouard Louis, et al.
Clinical and Experimental Immunology|December 14, 2024
Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled studyJohn Whalen, Anita Chandra, Sven Kracker, et al.
Contemporary Clinical Trials|December 6, 2020
Reporting and design of randomized controlled trials for COVID-19: A systematic reviewAlison Dillman, Jay J H Park, Michael J Zoratti, et al.
The Lancet. Global Health|April 18, 2021
The role and challenges of cluster randomised trials for global healthLouis Dron, Monica Taljaard, Yin Bun Cheung, et al.
JAMA Network Open|July 12, 2022
Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional TrialsJay J H Park, Behnam Sharif, Ofir Harari, et al.
Clinical and Translational Science|July 19, 2023
Totality of evidence of the effectiveness of repurposed therapies for COVID-19: Can we use real-world studies alongside randomized controlled trials?Jaap Mandema, Hugh Montgomery, Louis Dron, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19Craig R Rayner, Louis Dron, Jay J H Park, et al.
Pageof 4